EMD Millipore: Depend(Ab)le – Stem Cell Antibodies
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research…
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research. We provide widely published stem cell targets as well as a comprehensive set of research tools for characterising stem cells. We are also continuously providing novel antibodies for emerging stem cell markers. Our characterisation kits include panels of antibodies used to comprehensively analyse multiple differentiation pathways.
Downloads
Feature: Depend(Ab)le Stem Cell Antibodies
Learn More
Click here to find out more about stem cell antibodies
Related content from this organisation
- Product hub: Light the path to your next neuroscience discovery with a new ultrasensitive NF-L immunoassay
- A high-throughput macrodomain assay to identify coronavirus drugs
- Building a powerful portfolio of sepsis biomarker signatures for therapeutic clinical trials
- Drug Target Review Assays ebook 2022
- Product hub: Stay at the forefront of neuroscience research
Related topics
Assays, Drug Discovery Processes, Drug Targets, Screening, Stem Cells, Translational Science
Related organisations
Merck KGaA
